Ipilimumab Biosimilar - Research Grade

Product Sizes

1 mg

ICH4025-1MG

5 mg

ICH4025-5MG

10 mg

ICH4025-10MG

20 mg

ICH4025-20MG

50 mg

ICH4025-50MG

100 mg

ICH4025-100MG

200 mg

ICH4025-200MG

500 mg

ICH4025-500MG

1 g

ICH4025-1G

About this Product

SKU:: ICH4025
Additional Names:: Ctla4, Cytotoxic T-lymphocyte protein 4, CD152
CE/IVD:: RUO
Clonality:: Recombinant Monoclonal
Concentration:: 1-5 mg/ml
Extra Details:: Ipilimumab biosimilar is a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab biosimilar is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Ipilimumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
Formulation:: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Host:: Human
Immunogen:: CTLA-4
Isotype:: IgG1, kappa
Purity:: >95%
Purification:: Protein A/G Purified
Reactivities:: Human
Shipping Conditions:: Blue Ice
Specificity:: Detects human CTLA-4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ipilimumab.
Storage Conditions:: 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
Supplier:: ichorbio
Type:: Antibody: Biosimilar Antibody
Shipping Costs:: Free shipping to UK Customers

Basket